Christophe LE TOURNEAU

Date of Birth:                      January 20, 1974                                           
Nationality:                         French

Professional Address:      Department of Drug Development and Innovation (D³i)
Institut Curie – 26, rue d’Ulm – 75005 Paris – France

Phone :                                +33-1-4432-4675
Facsimile :                          +33-1-5310-4041
E-mail :                                Christophe.LeTourneau@curie.fr
N° RPPS                              10003987137

Education:

2007           PhD, Thesis of Sciences
2005           Certified in Medical Oncology
2003           MD, Thesis of Medicine

Position:

Since January 2018 : Head of the Department of Drug Development and Innovation (D³i), Institut Curie, Paris & Saint-Cloud, France

Since September 2016 : Professor of medicine – Versailles-Saint-Quentin-en-Yvelines University

Since November 2009 : Medical Oncologist, Clinical Trial Unit – Department of Medical Oncology, Institut Curie, Paris, France – Head of Early Phase Clinical Trials and Head & Neck Oncology

2007 – 2009 : Clinical Fellowship, Drug Development Program, Department of Medical Oncology (Pr Siu), Princess Margaret Hospital, Toronto, Canada

2005 – 2007 : Assistant Professor of Oncology, Paris VII University. Departement of Medical Oncology (Pr Raymond), Beaujon University Hospital, Clichy

2004 – 2005 : Assistant of Oncology, Department of Medical Oncology (Pr Pouillart), Institut Curie, Paris

2000 – 2004 : Resident, graduated MD in the Faculty and Hospitals of Strasbourg, training in medical oncology, radiotherapy and public health.

1994 – 2000 : Medical student, Paris V University

Committees:                                                                                         

• ASCO

• Member scientific program committee – Developmental therapeutics (2017 – 2019)
• Chair scientific program committee – Developmental therapeutics (2018)

• ESMO

• Member scientific program committee – Head & Neck (2014, 2017 & 2019)
• Member scientific program committee – Developmental therapeutics (2018)

• ICHNO

• Member scientific program committee – Head & Neck (2017)

• ESMO Asia

• Co-chair scientific program committee – Personalized Medicine (2017)
• Member scientific program committee – Head & Neck (2018)

Editorial activities:

JCO Precision Oncology: Member of the Editorial Board (2017 – )
Lancet Oncology: Member of the International Advisory Board (2018 – )

Publications: 120+

International talks: 60+